Insoluble 3D transdermal microcrystalline facial mask
By designing an insoluble 3D transdermal microcrystalline surface film, the microcrystalline needle tip layer avoids sensitive areas on the face, solving the problems of low penetration efficiency and poor user experience of existing surface films, and achieving more efficient ingredient absorption and a better user experience.
Patent Information
- Application Number
- CN202420890718.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Utility models(China)
- Current Assignee / Owner
- Filing Date
- 2024-04-26
- Publication Date
- 2025-02-25
- Estimated Expiration
- 2034-04-26
AI Technical Summary
When used, the existing surface mask has low penetration efficiency of the active ingredients, and strong stimulation when used in sensitive areas of the face, which makes the user experience poor.
An insoluble 3D transdermal microcrystalline surface film was designed, including the base layer of the membrane cloth and the insoluble microcrystalline needle tip layer. The microcrystalline needle tip layer avoids the sensitive area of the face, the needle tip height and diameter are moderate, and the material is polylactic acid and other organisms. Compatible materials.
It improves the absorption rate of active ingredients, reduces the application time of the facial mask, improves the user experience, and avoids the stimulation of sensitive areas on the face.
Smart Images

Figure CN222517346U_ABST
Abstract
Description
Technical Field
[0001] The utility model relates to the technical field of skin care products, in particular to an insoluble 3D transdermal microcrystalline facial mask. Background Art
[0002] Traditional facial mask products are applied to the surface of the face, allowing the active ingredients in the essence of the facial mask to penetrate into the skin naturally. However, due to the natural barrier effect of the stratum corneum of the human skin, the penetration efficiency of the active ingredients is low, and most of the active ingredients remain on the surface and cannot really penetrate into the skin. At the same time, if the facial mask is used for too long or frequently, it may cause the stratum corneum to be over-hydrated, destroy the skin barrier, and make the skin sensitive and fragile. Therefore, it is particularly important to improve the absorption efficiency of the active ingredients of the facial mask.
[0003] Patent CN215504476U discloses an active peptide microneedle mask, including a microneedle layer, a mask layer, an active functional layer and a closed layer, wherein: the microneedle layer includes an inner surface facing the skin and an outer surface away from the skin, the inner surface protrudes toward the skin to form a microneedle array, the mask is located on the outer surface of the microneedle layer and an active functional layer is also filled between the mask layer and the microneedle layer; the closed layer is located on the side of the mask layer away from the microneedle layer and can completely wrap the mask layer. Patent CN209204470U discloses a microneedle transdermal drug delivery biological mask, including: a mask base, and a microneedle array disposed on the mask base, the microneedle array is composed of a plurality of microneedle bodies arranged at a preset spacing, the microneedle bodies include hollow solid microneedles, a hollow drug delivery pipeline disposed inside the hollow solid microneedles, and a drug delivery cavity in the hollow drug delivery pipeline.
[0004] In view of the above-mentioned related technologies, the inventors believe that the following defects exist: (1) The active peptide microneedle mask is provided to fit sensitive facial areas such as the philtrum and temples. The microneedles here will cause greater irritation or even pain when piercing the skin; at the same time, compared with existing conventional facial masks, the microneedle mask has a complex structure, and the steps for users to use it are cumbersome, which has the problem of poor user experience. (2) The microneedle transdermal drug delivery biological mask has a complex structure. During use, it is necessary to apply creamy, semi-fluid or fluid skin care products on the surface of the mask, which is inconvenient to use; at the same time, the biological mask does not have a crack on the membrane cloth, and the problem of the fit of the mask when used is not considered. For this reason, the utility model proposes an insoluble 3D transdermal microcrystalline facial mask. Utility Model Content
[0005] Based on the above problems, the main purpose of the present invention is to provide an insoluble 3D transdermal microcrystalline facial mask to solve the defects and shortcomings in the prior art.
[0006] In order to solve the above problems, the utility model provides an insoluble 3D transdermal microcrystalline facial mask, comprising: a membrane cloth base layer, and an insoluble microcrystalline needle tip layer arranged on the base layer, wherein the base layer and the insoluble microcrystalline needle tip layer are integrally formed; four cracks are arranged around the periphery of the membrane cloth base layer, and the cracks include those corresponding to the upper sides of the temples and both sides of the mandible on both sides of the human face; the membrane cloth base layer is provided with openings, which respectively correspond to the eyes, nose and mouth of the human face; the insoluble microcrystalline needle tip layer is formed by microcrystalline needles arranged according to a preset spacing, and is located on the inner side of the membrane cloth base layer.
[0007] Furthermore, the membrane fabric base layer is one of non-woven fabric, gauze, silk, Tencel, biofiber membrane, and ultrafine fiber membrane;
[0008] Furthermore, the insoluble microcrystalline needle tip layer avoids four sensitive facial areas, namely, the philtrum, around the eyes, around the lips and the temples.
[0009] Furthermore, the needle tip height of the insoluble microcrystalline needle tip layer is 70-300 microns, and the bottom diameter is 20-100 microns.
[0010] Furthermore, the insoluble microcrystalline needle tip layer material is one of polylactic acid, polylactic acid-glycolic acid copolymer, poly(methyl vinyl ether maleic acid), and methacrylic hyaluronic acid, and the needle body structure is one of a cone, a pyramid, or a bullet head.
[0011] Beneficial effects of the utility model:
[0012] 1. The utility model has a simple structure and can be packaged in the same package as the facial mask essence. It is used in the same way as conventional facial masks and does not require additional steps. At the same time, the facial mask of the utility model is provided with four cracks, making it closer to the skin when used, and the microneedle layer of the facial mask avoids sensitive facial areas such as the philtrum and temples, thus greatly improving the user experience.
[0013] 2. Compared with the prior art, the insoluble 3D transdermal microcrystalline facial mask provided by the utility model can create micron-level channels invisible to the naked eye on the skin barrier when used, so that the effective ingredients in the essence can directly pass through the skin barrier and enter the skin, effectively improving the absorption rate and active effect of the corresponding effective ingredients, reducing the application time of the microcrystalline facial mask, and providing convenience for users. BRIEF DESCRIPTION OF THE DRAWINGS
[0014] The accompanying drawings are used to provide a further understanding of the present invention and constitute a part of the specification. Together with the embodiments of the present invention, they are used to explain the present invention and do not constitute a limitation of the present invention. In the accompanying drawings:
[0015] Figure 1 It is a schematic diagram of the structure of the outer side of the utility model.
[0016] Figure 2 It is a schematic diagram of the structure of the internal test of the utility model.
[0017] Figure 3 It is a schematic diagram of the cone structure of the insoluble microcrystalline needle tip layer needle body of the utility model.
[0018] Figure 4 It is a schematic diagram of the pyramid structure of the insoluble microcrystalline needle tip layer of the utility model.
[0019] Figure 5 It is a schematic diagram of the structure of the bullet body of the insoluble microcrystalline needle tip layer needle body of the utility model. DETAILED DESCRIPTION
[0020] The technical solutions in the embodiments of the present invention will be described clearly and completely below in conjunction with the drawings in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, rather than all of the embodiments.
[0021] Examples of the embodiments are shown in the accompanying drawings, wherein the same or similar reference numerals throughout denote the same or similar elements or elements having the same or similar functions.
[0022] The following is combined with Figure 1-5 This application is described in further detail.
[0023] The present application embodiment discloses an insoluble 3D transdermal microcrystalline facial mask, comprising:
[0024] A membrane cloth base layer 1 and an insoluble microcrystalline needle tip layer 2 arranged on the base layer 1.
[0025] As mentioned above, the membrane cloth base layer 1 is one of non-woven fabrics, gauze, silk, Tencel, biofiber membrane, and ultrafine fiber membrane. Therefore, the microcrystalline facial mask has good air permeability and good adhesion to the facial mask essence, thereby improving the use effect of the product.
[0026] As mentioned above, four slits 3 are provided around the base layer 1 of the membrane cloth, which specifically correspond to the upper sides of the temples and the sides of the mandible on both sides of the human face, so that it can better adapt to the three-dimensional shape of the human face when used, so that the facial mask can better fit the facial contour and improve the use effect of the facial mask.
[0027] As mentioned above, the base layer 1 of the membrane cloth is also provided with openings, which respectively correspond to the eyes a1, nose a2 and mouth a3 of the human face, wherein the eyes a1 and mouth a3 are both elliptical openings, and the nose a2 is an arc-shaped opening. The above shape design is more in line with the facial structure of the human face, and facilitates the movement of the eyes, nose and mouth when the microcrystalline facial mask is applied to the face.
[0028] As mentioned above, the insoluble microcrystalline needle tip layer 2 is formed by microcrystalline needle bodies 21 arranged at a preset interval and is located on the inner side of the membrane cloth base layer 1 .
[0029] As mentioned above, the preset spacing range of the insoluble microcrystalline needle tip layer does not include the four sensitive facial areas of the philtrum, around the eyes, around the lips and the temples, so the microcrystalline needle body 21 will not approach the skin of these four areas of the user during use. In the process of the microcrystalline needle body 21 penetrating the skin, it is not easy to cause a large sense of irritation or pain to the skin in the areas near the philtrum, around the eyes, around the lips and the temples, thereby effectively improving the product usage experience.
[0030] As mentioned above, the height of the insoluble microcrystalline needle body 21 is 70-300 microns, and the bottom diameter is 20-100 microns, so when used, the microcrystalline needle body 21 can penetrate the epidermis of the skin, and can create a micron-level channel invisible to the naked eye on the skin barrier, but it does not touch the nerves of the dermis, is not easy to cause discomfort, and effectively improves the experience and the absorption efficiency of the effective ingredients.
[0031] The insoluble microcrystalline needle material is one of polylactic acid, polylactic acid-glycolic acid copolymer, poly(methyl vinyl ether maleic acid), and methacrylic acid hyaluronic acid.
[0032] As mentioned above, the insoluble microcrystalline needle 21 has a cone structure ( Figure 3 ), pyramid ( Figure 4 ) or bullet body ( Figure 5 ) to facilitate penetration into the epidermis of the skin.
[0033] As described above, the membrane cloth base layer 1 and the insoluble microcrystalline needle tip layer 2 are integrally formed, the structure is simple, and the membrane cloth base layer 1 and the insoluble microcrystalline needle tip layer 2 can be directly packaged in the same package as the facial mask essence, and the production process is simple.
[0034] The embodiments of the present invention are described in detail above in conjunction with the accompanying drawings, but the present invention is not limited to the above embodiments. Various changes can be made within the knowledge scope of ordinary technicians in the technical field without departing from the purpose of the present invention.
Claims
1. An insoluble 3D transdermal microcrystalline facial mask, characterized in that: include: A membrane cloth base layer, and an insoluble microcrystalline needle tip layer disposed on the base layer; Wherein, the membrane cloth base layer and the insoluble microcrystalline needle tip layer are integrally formed; The periphery of the base layer of the membrane cloth is provided with four cracks, the cracks including the upper sides of the temples and the two sides of the mandible corresponding to the two sides of the human face; The insoluble microcrystalline needle tip layer avoids four sensitive facial areas, namely, the philtrum, around the eyes, around the lips and the temples.
2. The insoluble 3D transdermal microcrystalline facial mask according to claim 1, characterized in that: The membrane cloth base layer is one of non-woven fabrics, gauze, silk, tencel, biological fiber membrane and ultrafine fiber membrane.
3. The insoluble 3D transdermal microcrystalline facial mask according to claim 2, characterized in that: The base layer of the membrane cloth is provided with openings corresponding to the eyes, nose and mouth of the human face.
4. The insoluble 3D transdermal microcrystalline facial mask according to claim 1, characterized in that: The insoluble microcrystalline needle tip layer is formed by microcrystalline needles arranged according to a preset interval and is located on the inner side of the membrane cloth base layer.
5. The insoluble 3D transdermal microcrystalline facial mask according to claim 4, characterized in that: The insoluble microcrystalline needle tip layer has a needle tip height of 70-300 microns and a bottom diameter of 20-100 microns.
6. The insoluble 3D transdermal microcrystalline facial mask according to claim 5, characterized in that: The insoluble microcrystalline needle tip layer material is one of polylactic acid, polylactic acid-glycolic acid copolymer, poly(methyl vinyl ether maleic acid), and methacrylic acid hyaluronic acid, and the needle body structure is a cone, a pyramid, or a bullet head.
Citation Information
Patent Citations
Microneedle transdermal drug delivery biological mask
CN209204470U